{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T11:50:58Z","timestamp":1788609058855,"version":"build-2803163510"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,3,22]],"date-time":"2018-03-22T00:00:00Z","timestamp":1521676800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s10620-018-5011-x","type":"journal-article","created":{"date-parts":[[2018,3,22]],"date-time":"2018-03-22T08:38:34Z","timestamp":1521707914000},"page":"1348-1354","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis"],"prefix":"10.1007","volume":"63","author":[{"given":"Cumali","family":"Efe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haider Al","family":"Taii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henriette","family":"Ytting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Aehling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahima A.","family":"Bhanji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannes","family":"Hagstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tugrul","family":"Purnak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Muratori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e5rten","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Muratori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Klintman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas D.","family":"Schiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo J.","family":"Montano-Loza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fin Stolze","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naim","family":"Alkhouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ersan","family":"Ozaslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Heneghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric M.","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Staffan","family":"Wahlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,22]]},"reference":[{"key":"5011_CR1","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1002\/hep.23584","volume":"51","author":"MP Manns","year":"2010","unstructured":"Manns MP, Czaja AJ, Gorham JD, et al. Diagnosis and management of autoimmune hepatitis. Hepatology. 2010;51:2193\u20132213.","journal-title":"Hepatology"},{"key":"5011_CR2","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.bpg.2011.10.007","volume":"25","author":"G Mieli-Vergani","year":"2011","unstructured":"Mieli-Vergani G, Vergani D. Autoimmune liver diseases in children-what is different from adulthood? Best Pract Res Clin Gastroenterol. 2011;25:783\u2013795.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"5011_CR3","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","volume":"63","author":"European Association for the Study of the Liver","year":"2015","unstructured":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines: autoimmune hepatitis. J Hepatol. 2015;63:971\u20131004.","journal-title":"J Hepatol"},{"key":"5011_CR4","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1136\/gut.2010.235259","volume":"60","author":"D Gleeson","year":"2011","unstructured":"Gleeson D, Heneghan MA. British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis. Gut. 2011;60:1611\u20131629.","journal-title":"Gut"},{"key":"5011_CR5","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1007\/s10620-012-2151-2","volume":"57","author":"AJ Czaja","year":"2012","unstructured":"Czaja AJ. Advances in the current treatment of autoimmune hepatitis. Dig Dis Sci. 2012;57:1996\u20132010.","journal-title":"Dig Dis Sci"},{"key":"5011_CR6","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jhep.2009.02.024","volume":"51","author":"MM Aw","year":"2009","unstructured":"Aw MM, Dhawan A, Samyn M, Bargiota A, Mieli-Vergani G. Mycophenolate mofetil as rescue treatment for autoimmune liver disease in children: a 5-year follow-up. J Hepatol.. 2009;51:156\u2013160.","journal-title":"J Hepatol."},{"key":"5011_CR7","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.3109\/00365521.2014.998271","volume":"50","author":"H Ytting","year":"2015","unstructured":"Ytting H, Larsen FS. Everolimus treatment for patients with autoimmune hepatitis and poor response to standard therapy and drug alternatives in use. Scand J Gastroenterol. 2015;50:1025\u20131031.","journal-title":"Scand J Gastroenterol"},{"key":"5011_CR8","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1016\/j.cgh.2017.06.001","volume":"15","author":"C Efe","year":"2017","unstructured":"Efe C, Hagstr\u00f6m H, Ytting H, et al. Efficacy and safety of Mycophenolate Mofetil and tacrolimus as second-line therapy for patients with autoimmune hepatitis. Clin Gastroenterol Hepatol.. 2017;15:1950\u20131956.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"5011_CR9","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.3748\/wjg.v13.i23.3232","volume":"13","author":"FS Larsen","year":"2007","unstructured":"Larsen FS, Vainer B, Eefsen M, Bjerring PN, Adel Hansen B. Low-dose tacrolimus ameliorates liver inflammation and fibrosis in steroid refractory autoimmune hepatitis. World J Gastroenterol. 2007;13:3232\u20133236.","journal-title":"World J Gastroenterol"},{"key":"5011_CR10","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.autrev.2006.11.001","volume":"6","author":"L Iaccarino","year":"2007","unstructured":"Iaccarino L, Rampudda M, Canova M, et al. Mycophenolate mofetil: what is its place in the treatment of autoimmune rheumatic diseases? Autoimmun Rev. 2007;6:190\u2013195.","journal-title":"Autoimmun Rev"},{"key":"5011_CR11","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.transproceed.2017.01.005","volume":"49","author":"T Sahutoglu","year":"2017","unstructured":"Sahutoglu T, Akgul SU, Caliskan Y, et al. Tac-MMF versus CsA-MMF\/CsA-AZA-based regimens in development of de novo complement-binding anti-HLA antibodies after kidney transplantation. Transplant Proc. 2017;49:454\u2013459.","journal-title":"Transplant Proc"},{"key":"5011_CR12","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1111\/j.1651-2227.2012.02745.x","volume":"101","author":"JR Marlaka","year":"2012","unstructured":"Marlaka JR, Papadogiannakis N, Fischler B, Casswall TH, Beijer E, N\u00e9meth A. Tacrolimus without or with the addition of conventional immunosuppressive treatment in juvenile autoimmune hepatitis. Acta Paediatr. 2012;101:993\u2013999.","journal-title":"Acta Paediatr"},{"key":"5011_CR13","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s12072-014-9558-0","volume":"9","author":"WS Lee","year":"2015","unstructured":"Lee WS, Lum SH, Lim CB, et al. Characteristics and outcome of autoimmune liver disease in Asian children. Hepatol Int. 2015;9:292\u2013302.","journal-title":"Hepatol Int"},{"key":"5011_CR14","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1136\/gut.50.5.713","volume":"50","author":"T Zolfino","year":"2002","unstructured":"Zolfino T, Heneghan M, Norris S, Harrison PM, Portmann BC, McFarlane IG. Characteristics of autoimmune hepatitis in patients who are not of European Caucasoid ethnic origin. Gut. 2002;50:713\u2013717.","journal-title":"Gut"},{"key":"5011_CR15","doi-asserted-by":"publisher","first-page":"727A","DOI":"10.1002\/hep.25656","volume":"56","author":"C Jimenez-Rivera","year":"2012","unstructured":"Jimenez-Rivera C, Graitson S, Critch J, et al. Incidence and characteristics of autoimmune hepatitis in children and adolescents in Canada: a preliminary report of The Canadian Pediatric Hepatology Research Group. Hepatology. 2012;56:727A.","journal-title":"Hepatology"},{"key":"5011_CR16","first-page":"302","volume":"23","author":"SM Dehghani","year":"2013","unstructured":"Dehghani SM, Haghighat M, Imanieh MH, et al. Autoimmune hepatitis in children: experiences in a tertiary center. Iran J Pediatr. 2013;23:302\u2013308.","journal-title":"Iran J Pediatr"},{"key":"5011_CR17","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/hep.22322","volume":"48","author":"EM Hennes","year":"2008","unstructured":"Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48:169\u2013176.","journal-title":"Hepatology"},{"key":"5011_CR18","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/MPG.0000000000001801","volume":"66","author":"G Mieli-Vergani","year":"2018","unstructured":"Mieli-Vergani G, Vergani D, Baumann U, et al. Diagnosis and management of paediatric autoimmune liver disease: ESPGHAN hepatology committee position statement. J Pediatr Gastroenterol Nutr. 2018;66:345\u2013360.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"5011_CR19","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/hep.510240201","volume":"24","author":"P Bedossa","year":"1996","unstructured":"Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology. 1996;24:289\u2013293.","journal-title":"Hepatology"},{"key":"5011_CR20","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.jhep.2016.11.013","volume":"66","author":"D Joshi","year":"2017","unstructured":"Joshi D, Gupta N, Samyn M, Deheragoda M, Dobbels F, Heneghan MA. The management of childhood liver diseases in adulthood. J Hepatol. 2017;66:631\u2013644.","journal-title":"J Hepatol"},{"key":"5011_CR21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/MPG.0000000000001530","volume":"65","author":"AN Zizzo","year":"2017","unstructured":"Zizzo AN, Valentino PL, Shah PS, Kamath BM. Second-line agents in pediatric patients with autoimmune hepatitis: a systematic review and meta-analysis. J Pediatr Gastroenterol Nutr. 2017;65:6\u201315.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"5011_CR22","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3109\/00365521.2015.1095351","volume":"51","author":"NN Than","year":"2016","unstructured":"Than NN, Wiegard C, Weiler-Normann C, et al. Long-term follow-up of patients with difficult to treat type 1 autoimmune hepatitis on Tacrolimus therapy. Scand J Gastroenterol. 2016;51:329\u2013336.","journal-title":"Scand J Gastroenterol"},{"key":"5011_CR23","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s12072-016-9767-9","volume":"10","author":"A Tanaka","year":"2016","unstructured":"Tanaka A, Ma X, Yokosuka O, et al. Autoimmune liver diseases in the Asia-Pacific region: proceedings of APASL symposium on AIH and PBC 2016. Hepatol Int. 2016;10:909\u2013915.","journal-title":"Hepatol Int"},{"key":"5011_CR24","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/ajg.2015.139","volume":"110","author":"HK Dhaliwal","year":"2015","unstructured":"Dhaliwal HK, Hoeroldt BS, Dube AK, et al. Long-term prognostic significance of persisting histological activity despite biochemical remission in autoimmune hepatitis. Am J Gastroenterol. 2015;110:993\u2013999.","journal-title":"Am J Gastroenterol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-018-5011-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-018-5011-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-018-5011-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T20:37:47Z","timestamp":1553200667000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-018-5011-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,22]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["5011"],"URL":"https:\/\/doi.org\/10.1007\/s10620-018-5011-x","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,22]]},"assertion":[{"value":"2 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}